JCI vs RAPT · P/E 44, rev $23.60B vs $132.1M cap
Johnson Controls International PLC (JCI) versus RAPT Therapeutics Inc (RAPT) — a side-by-side from cached financials, not a winner call.
Johnson Controls International PLC (JCI) is a building products & equipment company listed on NYSE.
RAPT Therapeutics Inc (RAPT) is a biotechnology company listed on US.
Latest reported JCI revenue for 2025-09-30 was $23.60B. Net income was $3.51B. JCI currently screens at market cap $87.62B and trailing P/E 43.9.
Latest reported RAPT revenue for 2023-12-31 was $0. Net income was -$116.8M. Revenue was down 100.0% from 2022-12-31 to 2023-12-31. RAPT currently screens at market cap $132.1M.
JCI currently screens at market cap $87.62B and trailing P/E 43.9. RAPT currently screens at market cap $132.1M.
Not investment advice. Open the JCI and RAPT stock pages for the full models.
Not investment advice.